BCI
PFE icon

Brinker Capital Investments’s Pfizer PFE Stock Holding History

Brinker Capital Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28 Buy
+1
New +$27 ﹤0.01% 2000

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Brinker Capital Investments's PFE Position: Q1 2026 in Review

Brinker Capital Investments reduced its Pfizer (PFE) stake by 12% in Q1 2026, selling an estimated $1.56M and leaving 446,491 shares worth $12.5M. The position accounts for 0.11% of the portfolio, ranked #169.

Brinker Capital Investments first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $27.1M in Q1 2023. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Brinker Capital Investments held 446,491 shares of Pfizer worth $12.5M as of Q1 2026.
  • Brinker Capital Investments sold 58,759 Pfizer shares in Q1 2026, an estimated $1.56M.
  • Pfizer made up 0.11% of Brinker Capital Investments's portfolio in Q1 2026, its #169 holding.
  • Brinker Capital Investments first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Brinker Capital Investments's Pfizer position peaked at $27.1M in Q1 2023.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.